Core Insights - Atlantic American Corporation reported a net income of $0.6 million, or $0.02 per diluted share, for Q3 2025, a significant improvement from a net loss of ($2.0) million, or ($0.10) per diluted share, in Q3 2024 [1] - For the nine-month period ended September 30, 2025, net income was $4.7 million, or $0.22 per diluted share, compared to a net loss of ($4.7) million, or ($0.24) per diluted share, in the same period of 2024 [1] - The increase in net income was primarily driven by higher premium revenue in automobile liability, inland marine, and automobile physical damage lines, as well as growth in Medicare supplement and group accident and health lines [1][2] Financial Performance - Operating income increased by $2.3 million in Q3 2025 compared to Q3 2024, and by $7.7 million for the nine-month period [2] - Premium revenue grew nearly 12% year-to-date, supported by new business and solid retention across both property & casualty and life & health segments [3] - Total revenue for Q3 2025 was $53.76 million, up from $44.52 million in Q3 2024, while total revenue for the nine-month period was $159.18 million, compared to $139.18 million in the same period of 2024 [8] Insurance Operations - Insurance premiums for life and health increased to $29.47 million in Q3 2025 from $27.57 million in Q3 2024, and for property and casualty, they rose to $22.5 million from $16.21 million [8] - Insurance benefits and losses incurred for life and health were $17.51 million in Q3 2025, compared to $16.78 million in Q3 2024, while property and casualty incurred losses increased to $17.96 million from $13.98 million [8] Balance Sheet Highlights - Total assets as of September 30, 2025, were $430.86 million, up from $393.43 million at the end of 2024 [9] - Total shareholders' equity increased to $109.49 million from $99.61 million [9] - Book value per common share rose to $5.10 from $4.61 [9]

Financial Performance - Atlantic American Corporation reported a net income of $0.4 million, or $0.02 per diluted share, for the three months ended December 31, 2024, compared to a net loss of $2.2 million, or $(0.11) per diluted share, for the same period in 2023 [1] - For the year ended December 31, 2024, the company had a net loss of $4.3 million, or $(0.23) per diluted share, compared to a net loss of $0.2 million, or $(0.03) per diluted share, for the year ended December 31, 2023 [1] - The increase in net income for the fourth quarter was primarily due to favorable loss experience in life and health operations, particularly in group life and Medicare supplement lines [1] Business Segments - The company experienced exceptional new sales in its Medicare supplement business during the fourth quarter annual enrollment period, with strong momentum continuing into the new year [2] - Rising costs in the commercial automobile market have affected profitability, prompting the company to take steps to improve rates for that line of business [2] Revenue and Expenses - Total revenue for the three months ended December 31, 2024, was $49.043 million, compared to $46.745 million for the same period in 2023 [7] - Insurance premiums for life and health increased to $29.351 million in Q4 2024 from $26.138 million in Q4 2023, while property and casualty premiums decreased slightly from $16.781 million to $16.053 million [7] - Total benefits and expenses for the three months ended December 31, 2024, were $48.498 million, down from $49.847 million in the same period in 2023 [7] Dividends and Shareholder Value - The Board of Directors approved an annual dividend of $0.02 per share, payable on April 23, 2025, to shareholders of record as of April 9, 2025 [2] Balance Sheet Highlights - As of December 31, 2024, total assets were $393.428 million, an increase from $381.265 million in 2023 [8] - Total shareholders' equity decreased to $99.613 million from $107.275 million in the previous year [8] - The book value per common share was $4.61, down from $4.99 in 2023 [8]